Archive

New vaccine could help halt Alzheimer’s progression

Written by Charlie King | 12 Nov 2020

Our immune system’s capacity to mount a well-regulated defence against foreign substances, including toxins, weakens with age and makes vaccines less effective in people over age 65..

Cannabis reduces OCD symptoms by half in the short-term

Written by Charlie King | 21 Oct 2020

People with obsessive-compulsive disorder, or OCD, report that the severity of their symptoms was reduced by about half within four hours of smoking cannabis, according to a Washington… read more.

Balancing the response to covid-19

Written by Christine Clark | 18 Oct 2020

Article written by Christine Clark As politicians grapple with the idea of a lockdown or a more stringent lockdown GPs have called for an end to the ‘one-track’… read more.

Dozens of blood pressure drugs do not elevate risk of depression

Written by Bruce Sylvester | 9 Oct 2020

Article written by Bruce Sylvester Dozens of the most widely used blood pressure medications show no tendency to elevate risk of depression, Danish researchers report.

Pesco-Mediterranean diet, intermittent fasting may lower heart disease risk

Written by Charlie King | 7 Oct 2020

A Pesco-Mediterranean diet rich in plants, nuts, whole grains, extra-virgin olive oil, and fish and/or seafood is ideal for optimizing cardiovascular health, according to a cumulative review published… read more.

Hostility linked with higher risk of death after second heart attacks

Written by Charlie King | 5 Oct 2020

Heart attack patients who are sarcastic or irritable could be putting their health at risk, according to research published today in the European Journal of Cardiovascular Nursing, a journal… read more.

Depression, but not anxiety, linked with inflammation and metabolic change

Written by Charlie King | 4 Oct 2020

Anxiety and depression are often linked and assumed to be closely related, but now research has shown for the first time that depression and anxiety have different biochemical… read more.

Doctors develop system which can predict Bipolar Disorder 4 years before onset

Written by Charlie King | 1 Oct 2020

An international team of doctors have developed a machine learning system which can predict the development of Bipolar Disorder up to 4 years before onset in young people:… read more.

Older people with early, asymptomatic Alzheimer’s at risk of falls

Written by Charlie King | 23 Sep 2020

Falls are the leading cause of fatal injuries in older adults, causing more than 800,000 hospitalizations and about 30,000 deaths in the U.S. every year. Some risk factors… read more.

Top-line results from the phase III CLARITY study evaluating pimavanserin for the adjunctive treatment of major depressive disorder.-Acadia Pharmaceuticals.

Written by MUOL News | 23 Jul 2020

Acadia Pharmaceuticals Inc. announced top-line results from its 298 patient Phase III CLARITY study which combined two identical, double-blind, placebo-controlled studies evaluating the efficacy, safety and tolerability of… read more.

Soleno Therapeutics announces top-line results from phase III trial of DCCR for treatment of Prader-Willi syndrome.

Written by MUOL News | 14 Jun 2020

Soleno Therapeutics, Inc. announced top-line results from the Company’s Phase III trial, DESTINY PWS (C601), evaluating once-daily Diazoxide Choline Controlled Release (DCCR) tablets for patients with Prader-Willi Syndrome… read more.

STRIDE-1 Phase III Trial of AXS 05 meets key secondary endpoints in depression.- Axsome Therapeutics

Written by MUOL News | 1 Apr 2020

Axsome Therapeutics announced that AXS 05 (bupropion + dextromethorphan) met key secondary endpoints in the STRIDE-1 trial by rapidly and statistically significantly improving symptoms of depression on the… read more.

« Previous 1 … 18 19 20 21 22 … 29 Next »

Archive

Subscribe for our mailing list

Follow Us